API Holdings Announces Full Term‑Loan Repayment and Debt‑Free Status

On 17 August 2026, API Holdings, the ultimate parent of Thyrocare, confirmed that it has cleared its outstanding term loan of ₹1,050 crore, thereby becoming a debt‑free entity. The repayment was financed through the proceeds from the recent sale of a portion of its stake in Thyrocare Technologies as well as internal accruals.

Stake Sale and Pledge Release

Docon Technologies Private Limited, the promoter and holding company of Thyrocare, disposed of 15,769,696 Thyrocare shares, representing approximately 9.90 % of the company’s paid‑up equity share capital, via market trades. Following the transaction, Docon retains a 51.02 % promoter holding in Thyrocare, and the pledge that had been linked to the term loan on the remaining shares has been fully released, leaving the entire stake unencumbered.

Executive Commentary

  • Alok Kumar Jagnani, Whole‑Time Director and Group CFO of API Holdings, stated: “We’ve repaid our term debt in full, and we did it the hard way, without diluting our stake in Thyrocare below 51 %. That’s the real headline: a stronger balance sheet without giving up our ownership. It reflects a capital allocation philosophy where growth and discipline aren’t traded off against each other. With every business in the group soon profitable, there’s no drag left on the P&L; just a clean base to build from.”
  • Siddharth Shah, Vice Chairman of API Holdings, added: “The Thyrocare acquisition has worked out well for API. Shareholders who held on instead of tendering to our open offer at ₹433 per share in July 2021 (bonus adjusted) are sitting on ₹653 at close of trading on 14 August 2026 – dividends included. That’s a 51 % return. NIFTY 50 gave you 41 %. Pathology peers weren’t even close. True value for money!”
  • Rahul Guha, MD & CEO of API Holdings and Thyrocare, remarked: “Zero debt isn’t the finish line; it’s the starting gun. This wasn’t financial engineering; it was Thyrocare’s and the group’s execution, quarter after quarter, that made it possible. What the team proved is bigger than a balance sheet: this organisation can execute on anything it sets its mind to. That’s the real asset we’re carrying into the next chapter.”

Outlook

With the term loan fully repaid and all businesses moving toward profitability, API Holdings indicated that it is now positioned to pursue its next phase focused on profitable growth, disciplined execution, and long‑term value creation across its healthcare portfolio.

---

Disclaimer: The above press release comes to you under an arrangement with PNN. PTI takes no editorial responsibility for the same.